NClip

Geriatric Assessment and Polypharmacy Safety

6 min read

Geriatric Assessment and Polypharmacy Safety

Key Points

  • Comprehensive geriatric assessment (CGA) integrates function, cognition, mood, nutrition, pain, and social context.
  • The SPICES screen supports early detection of sleep, eating, continence, cognition, falls, and skin-risk changes.
  • Polypharmacy increases risk for interactions, delirium, falls, organ toxicity, and adherence failure.
  • Polypharmacy (five or more medications) increases mobility-impairing adverse drug events and mortality risk in frail older adults.
  • Functional screening must be paired with active follow-up, not documentation alone.
  • Elder-abuse surveillance is a nursing safety responsibility in all care settings.
  • Older adults have higher hospitalization and transition burden, so interdisciplinary coordination intensity should increase with complexity.
  • Functional-health screening should integrate ADL/IADL findings with cognition, mood, and quality-of-life tools (for example MMSE, GDS, and SF-12) when complexity rises.

Pathophysiology

Older adults often receive multiple concurrent therapies for multimorbidity. Age-related pharmacokinetic and pharmacodynamic changes can convert otherwise standard regimens into high-risk combinations, especially when sedation, orthostasis, anticholinergic effects, or renal-hepatic burden accumulate.

CGA improves outcomes by identifying interacting vulnerabilities early: cognitive impairment, mobility decline, nutritional imbalance, mood symptoms, abuse risk, and caregiver strain. Early correction prevents avoidable hospitalization and functional collapse.

Classification

  • CGA domain set: ADLs/IADLs, cognition, mood, pain, nutrition, falls, social supports, and advance preferences.
  • Functional-health toolset domain: ADL/IADL measures combined with MMSE, GDS, and SF-12 trend data.
  • Medication-risk domain: Drug-drug interactions, duplicate therapy, high-risk classes, and adherence burden.
  • Safety domain: Fall risk, home/environment hazards, and supervision mismatch.
  • Abuse-surveillance domain: Physical, psychological, neglect, and financial exploitation indicators.
  • Abuse-screening domain: EASI, H-S/EAST, and VASS can support suspicion screening but do not replace diagnostic evaluation.
  • Elder/adult-at-risk abuse-type domain: Physical, sexual, emotional, neglect, financial exploitation, treatment without consent, and unreasonable confinement/restraint.
  • Risk-population domain: Adults age 60+ and adults at risk with conditions that impair independent self-care capacity.
  • Interdisciplinary-geriatrics domain: Team-based coordination across medical, psychological, and social needs as a high-reliability model for complex older adults.
  • Primary-medical-home fallback domain: When formal geriatric teams are unavailable, PCP-led cross-setting coordination maintains continuity.

Nursing Assessment

NCLEX Focus

Questions often test the safest next action when confusion, falls, and new medications occur together.

  • Assess complete medication list including OTC vitamins, supplements, and herbal products.
  • Assess medication count for polypharmacy threshold (five or more medications) and mobility-limiting adverse effects.
  • Assess for potentially inappropriate medications using evidence-based geriatric safety criteria.
  • Assess functional status trends with standardized ADL, cognition, and depression tools.
  • Use the SPICES framework as a rapid domain check and compare findings to patient baseline.
  • Assess for expected age-related change versus new unexpected findings that require provider notification or urgent escalation.
  • Assess cumulative fall-risk factors (recent fracture, opioid exposure, sensory deficits, assistive-device dependence, and prior fall history).
  • Assess for abuse/neglect indicators requiring escalation: unexplained bruises/cuts/burns/fractures, weight loss or malnourishment, poor hygiene/unkempt presentation, anxiety/depression/confusion, social withdrawal, and suspicious financial loss.
  • Assess injury-location and healing-pattern clues (for example maxillofacial injury, inner-arm or torso bruising, and recurrent injuries in different healing stages) that raise concern for mistreatment.
  • Assess for additional abuse indicators: sudden mental-status change not explained by known dementia trajectory, uncontrolled pain/conditions despite treatment, genital trauma or unexplained STI, and fear/discomfort around a caregiver.
  • Assess repeated emergency visits for injury patterns that may indicate unreported mistreatment.
  • Use screening tools such as EASI, H-S/EAST, or VASS when abuse is suspected, then escalate for full evaluation because these tools are indicators, not diagnostic confirmation.
  • Interview the older adult privately when feasible to improve disclosure safety and candor.
  • Assess care-utilization irregularities that can signal abuse or manipulation (for example repeated ED use, inconsistent follow-up, or caregiver-driven doctor shopping).
  • Document suspected abuse objectively with direct quotes and detailed injury/environment descriptions, adding photos per policy.
  • Assess cultural, language, and cognitive barriers that may reduce willingness or ability to disclose abuse.
  • Assess caregiver capacity, education needs, and respite-resource access.
  • Assess whether high-complexity older adults have access to interdisciplinary geriatric-team coordination or require explicit medical-home fallback planning.
  • Assess age-appropriate preventive-screening completion (for example colorectal screening, mammography, PSA shared decision, lipid/cholesterol testing, osteoporosis and AAA risk-based checks, and recurrent fall-risk review).

Nursing Interventions

  • Lead CGA workflow with interdisciplinary coordination and documented follow-through.
  • Escalate polypharmacy concerns to prescriber-pharmacist review and deprescribing discussion when appropriate.
  • Perform medication reconciliation at every care transition to reduce duplicate therapy and interaction-related injury risk.
  • Implement individualized fall and medication-adherence safety plans.
  • In care conferences, include patient/caregiver preferences for pain control, nutrition plans, and end-of-life decisions when clinically relevant.
  • Escalate critical unexpected findings immediately (for example chest pain, sudden focal neurologic deficits, refractory hypoxemia, suspected sepsis, or urine output <30 mL/hour).
  • Add environmental controls such as enhanced lighting, night-light use, and ready access to needed glasses/hearing aids.
  • Use validated elder-abuse screening pathways and mandated reporting procedures per policy.
  • Pair screening findings with coordinated follow-up planning so CGA, referral completion, and medication-safety actions are closed-loop rather than one-time checks.
  • Report suspected elder abuse or exploitation to local Adult Protective Services (APS) or designated channels; suspicion requires escalation even before full proof.
  • Use APS as a coordinated safety pathway: risk investigation plus outreach, crisis counseling, and linkage to medical, legal, social, and safe-housing resources.
  • Balance APS planning with patient autonomy by supporting self-determination whenever decisional capacity permits.
  • When caregiver strain contributes to risk, coordinate respite/support services and caregiver education to reduce recurrence risk.
  • In institutional-abuse concerns, escalate to long-term-care ombudsman and state licensing channels per policy.
  • Escalate suspected immediate criminal harm (for example assault or unlawful confinement) to law enforcement per jurisdiction and policy while maintaining patient safety.

Hidden Medication Risk

Unreviewed supplement use plus multiple prescriptions can create serious interactions despite “natural” product labeling.

Pharmacology

High-risk classes in older adults include benzodiazepines, sedative-hypnotics, anticholinergics, and interacting multi-drug combinations; nursing surveillance should prioritize cognition, gait safety, renal-hepatic burden, and real-world adherence. Use current AGS Beers Criteria to flag potentially inappropriate medications and reinforce single-pharmacy fill strategy, medication reconciliation, and pill-dispensing adherence supports.

Clinical Judgment Application

Clinical Scenario

An 82-year-old with recurrent falls uses seven prescriptions plus sleep supplements and reports new daytime confusion.

  • Recognize Cues: Polypharmacy with new cognitive and safety decline.
  • Analyze Cues: Interaction burden and sedative effects are likely contributors.
  • Prioritize Hypotheses: Immediate priority is preventing additional injury and evaluating medication-related delirium risk.
  • Generate Solutions: Start CGA, perform medication reconciliation, and request pharmacist-prescriber review.
  • Take Action: Implement fall precautions and targeted deprescribing/safety plan.
  • Evaluate Outcomes: Reduced confusion episodes, fewer falls, and safer medication routine.

Self-Check

  1. Which CGA components are most important after a new fall with confusion?
  2. Why should supplement review be mandatory in older-adult medication reconciliation?
  3. What findings should trigger immediate elder-abuse escalation?

Graph View